RSSS (Research Solutions, Inc.) Business Value to Revenue

researchsolutions.com (RSSS) - corporate logo

The EV/Sales multiple history demonstrates the business valuation dynamics, where the value 1205.39 captures this metric. Stability is ensured by providing physicians with access to US medical archives. Research Solutions (RSSS) is developing SaaS services for science while maintaining a comfortable work-life balance for employees. Simultaneously, Research Solutions (RSSS) successfully attracts AI and cloud technology experts, retaining key IT personnel.

RSSS Research Solutions: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/19/2026

Financial and market metric breakdowns for researchsolutions.com (RSSS)

Fundamental valuation:Research Solutions (RSSS)
Flagship merchandise of Research Solutions

Market expectations for Research Solutions (RSSS) often depend on the scalability of its revenue. The EV/Sales metric compares the total enterprise value with annual turnover, excluding the impact of debt load. By analyzing changes in EV/Sales, an investor determines the current overvaluation of the asset. A high valuation is justified by the inelastic demand for Article Galaxy and high customer switching costs. This confirms the fundamental resilience of the business amid any market volatility.

Competitor analysis for Research Solutions

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Business Value to Revenue NRC (National Research)|USA Mobility (SPOK) - Enterprise Value-to-Revenue Ratio|OPRX: Enterprise Value-to-Revenue Coefficient|Company Value to Revenue TBRG|simulations-plus.com (SLP) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio sophiagenetics.com (SOPH)|HCAT (Health Catalyst) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio CareCloud, Inc. CCLD|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)